| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 67028 |
Intravitreal injection of a pharmacologic agent |
50,841 |
43,583 |
$12.55M |
| 66984 |
Extracapsular cataract removal with insertion of intraocular lens prosthesis |
8,485 |
7,417 |
$4.73M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
115,186 |
112,676 |
$3.24M |
| 92235 |
|
49,723 |
49,195 |
$3.03M |
| 92250 |
|
91,836 |
91,174 |
$2.88M |
| 92134 |
|
109,603 |
108,287 |
$2.66M |
| J9035 |
Injection, bevacizumab, 10 mg |
32,275 |
26,992 |
$2.40M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
48,332 |
47,050 |
$2.15M |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
21,528 |
21,337 |
$1.47M |
| J0178 |
Injection, aflibercept, 1 mg |
995 |
916 |
$1.12M |
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
52,886 |
52,547 |
$994K |
| 67228 |
|
3,702 |
3,326 |
$904K |
| 92133 |
|
27,932 |
27,661 |
$688K |
| 15823 |
|
1,427 |
1,375 |
$530K |
| 92012 |
Ophthalmological services: medical examination and evaluation, intermediate, established patient |
25,250 |
24,497 |
$491K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
5,721 |
5,708 |
$447K |
| 92083 |
|
17,961 |
17,721 |
$435K |
| 92136 |
|
11,775 |
8,504 |
$324K |
| 68761 |
|
4,096 |
3,328 |
$314K |
| 66821 |
|
2,633 |
2,475 |
$239K |
| 67210 |
|
643 |
571 |
$194K |
| 92242 |
|
1,410 |
1,395 |
$189K |
| J7312 |
Injection, dexamethasone, intravitreal implant, 0.1 mg |
124 |
114 |
$133K |
| J7999 |
Compounded drug, not otherwise classified |
10,037 |
8,616 |
$111K |
| 67904 |
|
104 |
104 |
$60K |
| 92004 |
Ophthalmological services: medical examination and evaluation, comprehensive, new patient |
1,781 |
1,776 |
$52K |
| 92025 |
|
1,320 |
1,319 |
$33K |
| 92015 |
Determination of refractive state |
3,270 |
3,259 |
$24K |
| 65855 |
|
187 |
183 |
$23K |
| 65426 |
|
53 |
52 |
$20K |
| 66982 |
|
60 |
54 |
$19K |
| 67903 |
|
29 |
29 |
$19K |
| 67840 |
|
134 |
128 |
$18K |
| 92020 |
|
1,239 |
1,219 |
$17K |
| 92285 |
|
1,610 |
1,604 |
$14K |
| 76514 |
|
2,161 |
2,114 |
$14K |
| 66761 |
|
66 |
56 |
$13K |
| J2777 |
Injection, faricimab-svoa, 0.1 mg |
15 |
13 |
$11K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
401 |
392 |
$9K |
| J0585 |
Injection, onabotulinumtoxina, 1 unit |
23 |
12 |
$5K |
| 76512 |
|
82 |
75 |
$4K |
| 92002 |
|
47 |
47 |
$1K |
| 64612 |
|
24 |
24 |
$1K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
353 |
242 |
$1K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
16 |
16 |
$706.64 |
| 67820 |
|
26 |
25 |
$423.40 |
| 83861 |
|
16 |
12 |
$105.04 |